Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance.
- NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_assertion description "[Amplification of ERBB-2 was detected in 14 out of 63 (22%) cases of breast carcinoma, in 1 out of 23 patients with ovarian cancers, in 1 out of 19 cases of colon carcinoma and in 1 out of 27 patients with thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance.
- NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_assertion evidence source_evidence_literature NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance.
- NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_assertion SIO_000772 1349430 NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance.
- NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_assertion wasDerivedFrom befree-2016 NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance.
- NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_assertion wasGeneratedBy ECO_0000203 NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance.
- befree-2016 importedOn "2016-02-19" NP410926.RAM7XdcUL9iuny3NZcG6iQ2JoW-yiZmzq1G-bxMYiYQ0c130_provenance.